BioPharma Credit (LON:BPCR) Hits New 1-Year Low – Should You Sell?

BioPharma Credit (LON:BPCR)’s share price reached a new 52-week low on Thursday . The company traded as low as GBX 0.83 ($0.01) and last traded at GBX 0.83 ($0.01), with a volume of 219642 shares traded. The stock had previously closed at GBX 0.85 ($0.01).

BioPharma Credit Price Performance

The firm has a market capitalization of £9.96 million, a price-to-earnings ratio of 10.38 and a beta of 0.22. The firm has a 50 day moving average price of GBX 0.87 and a 200-day moving average price of GBX 0.88.

BioPharma Credit Cuts Dividend

The business also recently disclosed a dividend, which will be paid on Friday, February 28th. Stockholders of record on Thursday, January 30th will be paid a $0.03 dividend. This represents a dividend yield of 3.4%. The ex-dividend date of this dividend is Thursday, January 30th. BioPharma Credit’s payout ratio is presently 8,750.00%.

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.